IBM Aspera Faspex improper access control
CVE-2023-30995

7.5HIGH

Key Information:

Vendor

IBM
Status
Aspera Faspex
Vendor
CVE Published:
8 September 2023

What is CVE-2023-30995?

IBM Aspera Faspex versions 4.0 to 4.4.2 and 5.0 to 5.0.5 contain a vulnerability that could allow attackers to bypass IP whitelist restrictions by sending specially crafted HTTP requests. This flaw could enable unauthorized access, highlighting the importance of applying security updates promptly to safeguard your systems.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Aspera Faspex 5.0 <= 5.0.5

Aspera Faspex 4.0 <= 4.4.2

References

https://www.ibm.com/support/pages/node/7029681
vendor-advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/254268
vdb-entry
https://www.ibm.com/support/pages/node/7048851
vendor-advisory

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
None
Integrity:
High
Availability:
None
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
None
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.